RNA-binding protein CUGBP1 controls the differential INSR splicing in molecular subtypes of breast c

来源 :2019中国肿瘤学大会 | 被引量 : 0次 | 上传用户:zhulimin520
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Objective The insulin receptor gene(INSR)undergoes alternative splicing to give rise to two functionally related but also distinct isoforms IR-A and IR-B,which dictate proliferative and metabolic regulations,respectively.
其他文献
Objective The efficacy of immunotherapy treating EGFR-positive non-small cell lung cancer(NSCLC)patients has been proved to be limited.However,a series of mutantpatients could benefit from PD-1 blocka
Objective Hepatocellular carcinoma(HCC)is a life-threatening cancer and exhibits resistance to apoptosis.Fasting is reported to be associated with a decrease in tumor growth and induction of apoptosis
Objective Increased surface level of CIE(clathrin-independent endocytosis)proteins is a new feature of malignant neoplasms.CD147(EMMPRIN or Basigin)antigen is a multifunctional CIE glycoprotein highly
会议
Objective CCL2(Chemokine ligand-2)is a multifunctional factor,by acting via its receptor CCR2(chemokine receptor 2)which is expressed on monocytes and macrophages.
Objective With an incidence of 7,000±8,000 new cases per year worldwide,retinoblastoma(RB)is the most common primary intraocular malignant tumor in children.
会议
Objective Tob1,a member of Tob/BTG antiproliferative protein family,behaves as a tumor suppressor in many cancers,but its roles remains largely unknown.
会议
目的 肺癌的发病率和死亡率均居首位。近些年来,用于肿瘤的诊疗一体化研究引起广泛重视。大量研究表明,实体瘤由于肿瘤细胞的快速增殖、血管发育不完全而引起肿瘤内乏氧,导致缺氧相关性药物抵抗,从而使癌症治疗失败。
Objective Gastric cancer(GC)is the second leading cause of cancer-related deaths in China.As a small GTP-binding protein that belongs to an ARF protein subfamily,ARL4C is proposed to play a transducti
目的 甲状腺癌(thyroid carcinoma,TC)是最常见的内分泌恶性肿瘤。蛋白激酶A(protein kinase A,PKA)参与多种细胞的生物学调控。环化腺核苷一磷酸(Cyclic Adenosine monophosphate,cAMP)在真核生物中的主要功能是激活cAMP 依赖性蛋白激酶(PKA)。
目的 当前脑胶质瘤的诊断主要还是依赖各个单位的病理科诊断结果,按照中枢神经系统肿瘤的WHO 指南,脑胶质瘤的诊断需要综合病理结果和分子检测结果,因此,我们现在对脑胶质瘤的诊断不再单独依赖病理结果,而是将肿瘤标本进行全基因检测,根据检测结果指导术后精准治疗。